• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELWEAVE; GELWEAVE VALSALVA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELWEAVE; GELWEAVE VALSALVA Back to Search Results
Catalog Number 730032ADP
Device Problem Obstruction of Flow (2423)
Patient Problems Cardiac Arrest (1762); Infarction, Cerebral (1771); Thrombus (2101); Sudden Cardiac Death (2510)
Event Date 06/22/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).On (b)(6) postoperatively, 7 hours after the scheduled surgery, the patient had a massive infarction complicated by cardiac arrest that required a coronography showing left coronary artery occlusion warranting emergency resurgence for bypass surgery.During reintervention, thrombus of the aortic pellet was found to mold the valve and aortic prosthesis and to obstruct the common trunk.Thrombus extraction and double bypass were performed.During follow-up, the patient presented a multi-organ failure leading to his death on (b)(6) 2018 in intensive care at day 7.(b)(4).The manufacturing and qc records for this batch were retrieved and reviewed.Batch was manufactured to design specification.No further complaints have been received from this batch to date.Similar events review that was carried out for gelweave valsalva grafts with occlusion/thrombosis events gave a low occurrence rate of 0.01%.Vascutek are awaiting further information from site.
 
Event Description
Event was reported to vascutek as follows: gelweave valsalva graft was used for bentall procedure.Extensive thrombosis of the vascular graft occurred few hours after surgery, requiring surgical revascularization.Patient died of massive infarction.
 
Manufacturer Narrative
(b)(4).Manufacturer could not carry out further device analysis as it remains in situ.In the event intake form provided by the customer it was noted that the event might have been caused by thrombopenia induced by heparin (antibodies anti pf4 positive); however, this cause was not confirmed as no platelets aggregation test was carried out.Vascutek ltd now considers this complaint closed.Further action is not planned; however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
 
Event Description
This report is being submitted as follow up # 1 for mfr.Report # 9612515-2018-00009 to provide additional information that was received from the customer.More detailed event description was received on 19 jul 18: the patient was hospitalised for bentall elective surgery for annulo-ectasia disease with severe aortic leakage.Valved tube made of valsalva 32 tube and edwards carpenter perimount bio prosthesis of 25 gauge.Simple intervention - clamping 47min, cec 60min, total duration 175 min.The immediate follow up was simple - correct hemodynamics (no transfusion, no haemostatic products except 9 platelets units).On (b)(6) 2018 postoperatively, 7 hours after the scheduled surgery, the patient had a massive infarction complicated by cardiac arrest that required a coronarography showing left coronary artery occlusion that lead to the emergency bypass surgery.During reintervention, thrombus of the aortic pellet was found to mould the valve and aortic prosthesis and obstruct the common trunk.Thrombus extraction and double bypass were performed.During follow-up, patient presented a multi-organ failure leading to the patient's death on (b)(6) 2018 in intensive care at day7.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE
Type of Device
GELWEAVE VALSALVA
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
MDR Report Key7768054
MDR Text Key116595792
Report Number9612515-2018-00009
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881120140
UDI-Public05037881120140
Combination Product (y/n)N
PMA/PMN Number
K013022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Type of Report Initial,Followup
Report Date 07/12/2018,09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2021
Device Catalogue Number730032ADP
Device Lot Number17336807-1103
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/12/2018
Device Age1 MO
Event Location Hospital
Date Report to Manufacturer07/12/2018
Date Manufacturer Received07/12/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age71 YR
Patient Weight75
-
-